Exane Derivatives’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $221 | Hold |
20
| – | – | ﹤0.01% | 662 |
|
|
2022
Q1 | $333 | Hold |
20
| – | – | ﹤0.01% | 911 |
|
|
2021
Q4 | $382 | Hold |
20
| – | – | ﹤0.01% | 788 |
|
|
2021
Q3 | $493 | Hold |
20
| – | – | ﹤0.01% | 920 |
|
|
2021
Q2 | $495 | Hold |
20
| – | – | ﹤0.01% | 925 |
|
|
2021
Q1 | $633 | Hold |
20
| – | – | ﹤0.01% | 754 |
|
|
2020
Q4 | $928 | Hold |
20
| – | – | ﹤0.01% | 670 |
|
|
2020
Q3 | $658 | Hold |
20
| – | – | ﹤0.01% | 632 |
|
|
2020
Q2 | $549 | Hold |
20
| – | – | ﹤0.01% | 585 |
|
|
2020
Q1 | $599 | Hold |
20
| – | – | ﹤0.01% | 553 |
|
|
2019
Q4 | $473 | Sell |
20
-374
| -95% | -$8.85K | ﹤0.01% | 587 |
|
|
2019
Q3 | $7.17K | Sell |
394
-7,406
| -95% | -$135K | ﹤0.01% | 414 |
|
|
2019
Q2 | $191K | Buy |
+7,800
| New | +$191K | 0.03% | 270 |
|